In people with post-acute COVID-19 sequelae and neuropsychiatric manifestations, the body's own MOTS‑c in neuron-derived extracellular vesicles was lower than in healthy controls.
In plain wordsIn people with long COVID and neuropsychiatric symptoms, natural MOTS‑c in neuron-derived vesicles was lower than in healthy controls.
- Peptide
- MOTS-c
- Outcome
- DecreaseMOTS-c in neuron-derived EVs, PASC with neuropsychiatric manifestations
- Study
n: not reported in source
- Comparator
- Healthy controls
- Outcome group
- Mitochondrial function · Nervous system and cognition
Source sentences
Exosome marker CD81-normalized NDEV mean levels of subunit 6 of MP respiratory chain complex I and subunit 10 of complex III, and neuroprotective MPs Humanin and mitochondrial open-reading frame of the 12S rRNA-c (MOTS-c) all were decreased significantly in PASC with NP but not in PASC without NP relative to controls.
1 context sentence(design, population, supporting numbers)
SARS-CoV-2 proteins and mitochondrial proteins (MPs) in enriched plasma neuron-derived extracellular vesicles (NDEVs) and astrocyte-derived EVs (ADEVs) were quantified in resolved acute COVID-19 without post-acute sequelae of SARS-CoV-2 (PASC), PASC without neuropsychiatric manifestations (NP), PASC…
This result measures the body's own MOTS-c. Nobody was given the peptide. It is not evidence about taking it.